| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO
2 companies
Christine Chambers is Chief Financial Officer at FUSE and has filed Form 4s across 2 companies. Christine Chambers's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $154K at current prices.
The biggest single holding is PETS (~$78K) as CFO. Net of sales, the PETS filings show accumulation of 6,888 shares.
Christine Chambers has 7 Form 4 filings on record from June 2023 to September 2026, across 3 companies: Chief Financial Officer at MicroVision (MVIS), 2026; Chief Financial Officer at Fusemachines (FUSE), 2026; CFO at Petmed Express (PETS), 2023–2024.
The 10 reported transactions were 4 stock awards, 3 dispositions back to the company, 2 option or other derivative awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $50K and no sales.
The only open-market purchase was 6,888 shares of PETS at an average $7.26 on November 3, 2023, about $50K. Twelve months later PETS was down 42%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2023 | PETS Petmed Express Inc | CFO | Buy | 6,888 | $7.26 | $50,006.88 | +53.0% | -12.6% | -41.9% |